Notice | Hisamitsu Pharmaceutical co.,inc.

2021.09.07Notice: Notice regarding the outbreak status of COVID-19 infection

2021.08.18Notice: Notification Regarding Honorary Chairman, Hisamitsu Pharmaceutical Co., Inc. Passes Away

2021.05.06Notice: Measures to Prevent the Spread of COVID-19 at the 119th Annual General Meeting of Shareholders

2020.11.09Notice: Notification of Voluntary Recall for Overseas Pharmaceutical Drug “SALONPAS_®” (2 Patches)

2020.07.03Notice: Notification of Voluntary Recall for Topical Analgesic Patch “SALONPAS HOT_®” (Category 3 OTC Drug in Japan)

2020.06.01Notice: The Company’s Future Initiatives against COVID-19

2020.05.08Notice: Continuation of the Company’s Initiatives against COVID-19

2020.04.28Notice: Measures to Prevent the Spread of COVID-19 at the 118th Annual General Meeting of Shareholders

2020.04.08Notice: The Company’s Initiatives against COVID-19

2019.11.27Notice: The homepage has been renewed.

2019.11.15Notice: Notice regarding The Nationwide Expansion of The “Hisamitsu Art Project”, a Tokyo 2020 Olympic and Paralympic Games Authorized Program

2019.05.24Notice: Hirotaka Nakatomi, Representative Director, Chairman of The Company, Received The Order of The Rising Sun, Gold Rays with Rosette